Showing results (21-30 of 196) with videos related to

Sort By:
Pageof 20
Neurobiology of Disease|January 13, 2006
Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cellsKenyon D Ogburn, Teodoro Bottiglieri, Zhiyou Wang, et al.
Alcohol (Fayetteville, N.Y.)|June 11, 2026
The Effects of Developmental Ethanol Exposure & Postnatal Choline Supplementation on Long-Term Choline MetabolismJessica A Baker, Karen J Thomas, Teodoro Bottiglieri, et al.
Metabolites|June 26, 2024
Metabolomic and Physiological Effects of a Cardiorenal Protective Diet Intervention in African American Adults with Chronic Kidney DiseaseMeera J Patel, Chiamaka Emerenini, Xuan Wang, et al.
Molecular Genetics and Metabolism|July 27, 2010
Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathwaysCharles R Roe, Teodoro Bottiglieri, Mary Wallace, et al.
The Journal of Biological Chemistry|May 19, 2005
Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemiaAngela M Devlin, Teodoro Bottiglieri, Frederick E Domann, et al.
Circulation Research|November 16, 2002
Structure of cerebral arterioles in cystathionine beta-synthase-deficient miceGary L Baumbach, Curt D Sigmund, Teodoro Bottiglieri, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Hyperhomocyst(e)inemia: a risk factor for cerebrovascular diseaseLucilla Parnetti, Valeria Caso, Serena Amici, et al.
Kidney Medicine|July 8, 2022
Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)Cara East, Kyle Bass, Ankit Mehta, et al.
Reviews in Cardiovascular Medicine|May 6, 2019
Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directionsSivakumar Sudhakaran, Teodoro Bottiglieri, Kristen M Tecson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's diseasePadraig E O'Suilleabhain, Teodoro Bottiglieri, Richard B Dewey, et al.
Pageof 20